These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 33332736)
1. Molecular events underlying the cell-to-cell transmission of α-synuclein. Choi YR; Park SJ; Park SM FEBS J; 2021 Dec; 288(23):6593-6602. PubMed ID: 33332736 [TBL] [Abstract][Full Text] [Related]
2. Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains. Longhena F; Faustini G; Varanita T; Zaltieri M; Porrini V; Tessari I; Poliani PL; Missale C; Borroni B; Padovani A; Bubacco L; Pizzi M; Spano P; Bellucci A Brain Pathol; 2018 Nov; 28(6):875-888. PubMed ID: 29330884 [TBL] [Abstract][Full Text] [Related]
3. Neuronal ApoE Regulates the Cell-to-Cell Transmission of α-Synuclein. Kang SJ; Kim SJ; Noh HR; Kim BJ; Kim JB; Jin U; Park SA; Park SM Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955451 [TBL] [Abstract][Full Text] [Related]
4. Microglia as modulators of exosomal alpha-synuclein transmission. Xia Y; Zhang G; Han C; Ma K; Guo X; Wan F; Kou L; Yin S; Liu L; Huang J; Xiong N; Wang T Cell Death Dis; 2019 Feb; 10(3):174. PubMed ID: 30787269 [TBL] [Abstract][Full Text] [Related]
6. The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration. Mahul-Mellier AL; Burtscher J; Maharjan N; Weerens L; Croisier M; Kuttler F; Leleu M; Knott GW; Lashuel HA Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4971-4982. PubMed ID: 32075919 [TBL] [Abstract][Full Text] [Related]
7. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease. Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933 [TBL] [Abstract][Full Text] [Related]
8. Proteolytic cleavage of extracellular α-synuclein by plasmin: implications for Parkinson disease. Kim KS; Choi YR; Park JY; Lee JH; Kim DK; Lee SJ; Paik SR; Jou I; Park SM J Biol Chem; 2012 Jul; 287(30):24862-72. PubMed ID: 22619171 [TBL] [Abstract][Full Text] [Related]
9. TNFRSF10B is involved in motor dysfunction in Parkinson's disease by regulating exosomal α-synuclein secretion from microglia. Dai M; Yan L; Yu H; Chen C; Xie Y J Chem Neuroanat; 2023 Apr; 129():102249. PubMed ID: 36791922 [TBL] [Abstract][Full Text] [Related]
10. α-Synuclein aggregation and transmission in Parkinson's disease: a link to mitochondria and lysosome. Wang R; Sun H; Ren H; Wang G Sci China Life Sci; 2020 Dec; 63(12):1850-1859. PubMed ID: 32681494 [TBL] [Abstract][Full Text] [Related]
11. Liquid-liquid Phase Separation of α-Synuclein: A New Mechanistic Insight for α-Synuclein Aggregation Associated with Parkinson's Disease Pathogenesis. Mukherjee S; Sakunthala A; Gadhe L; Poudyal M; Sawner AS; Kadu P; Maji SK J Mol Biol; 2023 Jan; 435(1):167713. PubMed ID: 35787838 [TBL] [Abstract][Full Text] [Related]
12. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Luk KC; Song C; O'Brien P; Stieber A; Branch JR; Brunden KR; Trojanowski JQ; Lee VM Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20051-6. PubMed ID: 19892735 [TBL] [Abstract][Full Text] [Related]
13. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Volpicelli-Daley LA; Luk KC; Patel TP; Tanik SA; Riddle DM; Stieber A; Meaney DF; Trojanowski JQ; Lee VM Neuron; 2011 Oct; 72(1):57-71. PubMed ID: 21982369 [TBL] [Abstract][Full Text] [Related]
15. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis. Mehra S; Sahay S; Maji SK Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581 [TBL] [Abstract][Full Text] [Related]
16. In vitro α-synuclein neurotoxicity and spreading among neurons and astrocytes using Lewy body extracts from Parkinson disease brains. Cavaliere F; Cerf L; Dehay B; Ramos-Gonzalez P; De Giorgi F; Bourdenx M; Bessede A; Obeso JA; Matute C; Ichas F; Bezard E Neurobiol Dis; 2017 Jul; 103():101-112. PubMed ID: 28411117 [TBL] [Abstract][Full Text] [Related]
17. Analysis of α-Synuclein in Exosomes. Tsunemi T; Ishiguro Y; Yoroisaka A; Hattori N Methods Mol Biol; 2021; 2322():41-45. PubMed ID: 34043190 [TBL] [Abstract][Full Text] [Related]
18. An Overview on the Role of α -Synuclein in Experimental Models of Parkinson's Disease from Pathogenesis to Therapeutics. Javed H; Kamal MA; Ojha S CNS Neurol Disord Drug Targets; 2016; 15(10):1240-1252. PubMed ID: 27658511 [TBL] [Abstract][Full Text] [Related]
19. The misfolding mystery: α-synuclein and the pathogenesis of Parkinson's disease. Negi S; Khurana N; Duggal N Neurochem Int; 2024 Jul; 177():105760. PubMed ID: 38723900 [TBL] [Abstract][Full Text] [Related]